Prospective study shows high tumor clearance rates in basal cell carcinoma, indicating an effective non-surgical treatment.
At 6 months, 97% of tumors (33/34) demonstrated clinical clearance, and all 33 tumors remained free of recurrence at 12 months. Scar outcomes were favorable, with mean POSAS patient and observer scores of 2.96 and 3.8 (on a 10-point scale), respectively. The 1064 nm Nd:YAG laser represents a promising, cosmetically favorable, and minimally invasive therapeutic option for BCC, particularly in patients who are suboptimal surgical candidates or who prefer non-surgical interventions.
No takes yet. Share an insight, caveat, or question.
Ahluwalia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: